# Exclusion of the Left Atrial Appendage (LAA) With the LAAx, Inc. TigerPaw System

> **NCT00962702** · PHASE2 · UNKNOWN · sponsor: **LAAx, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DEVICE:** LAAx TigerPaw System

## Key facts

- **NCT ID:** NCT00962702
- **Lead sponsor:** LAAx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2009-12
- **Final completion:** 2010-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962702, "Exclusion of the Left Atrial Appendage (LAA) With the LAAx, Inc. TigerPaw System". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00962702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*